He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at AstraZeneca.
Published: March 26, 2021 at 01:17AM
from NYT Health https://ift.tt/2NTHtbL
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at AstraZeneca.
Published: March 26, 2021 at 01:17AM
from NYT Health https://ift.tt/2NTHtbL